← Open Payments lookup

ROSALINDA ALAY: Open Payments

NPI 1437537289 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,412 in 151 payments from 24 companies in 2025. Trend: 2023 $3,149 · 2024 $2,143 · 2025 $3,412

Food & beverage: $3,309Education: $103
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$586
GlaxoSmithKline, LLC.24$346
United Therapeutics Corporation6$246
Regeneron Healthcare Solutions, Inc.10$217
Verona Pharma, Inc.18$205
Mallinckrodt Hospital Products Inc.7$197
Boehringer Ingelheim Pharmaceuticals, Inc.5$188
Viatris Specialty LLC10$186
Grifols USA, LLC2$177
Takeda Pharmaceuticals U.S.A., Inc.8$173

Products named: DUPIXENT, FASENRA, Ohtuvayre, ACTHAR, OFEV, YUPELRI, BREZTRI, Prolastin-C Liquid.

Industry payments across FL — which companies pay providers there.